Figure 4
Figure 4. Expression of CD27 and CD45RA on (virus-specific) CD8+ T cells in the PB and LNs. (A) Representative dot plots of CD27 and CD45RA staining, gated on total (n = 15), CMV-specific (n = 10, 5 donors were analyzed with 2 different tetramers), EBV-specific (n = 7, 4 donors were analyzed with 2 tetramers and 2 donors with 3 tetramers), and FLU-specific (n = 5) CD8+ T cells analyzed in paired samples from the PB and LNs. (B) Comparison of percentages of CD27−CD45RA+ (effector-type) cells within total and CMV-, EBV-, and FLU-specific CD8+ T cells between PB and LNs. (C) Comparison of the percentages of CD27+CD45RA+ (naive) cells within total CD8+ T cells between PB and LNs. Paired samples were analyzed using the Wilcoxon signed-rank test.

Expression of CD27 and CD45RA on (virus-specific) CD8+ T cells in the PB and LNs. (A) Representative dot plots of CD27 and CD45RA staining, gated on total (n = 15), CMV-specific (n = 10, 5 donors were analyzed with 2 different tetramers), EBV-specific (n = 7, 4 donors were analyzed with 2 tetramers and 2 donors with 3 tetramers), and FLU-specific (n = 5) CD8+ T cells analyzed in paired samples from the PB and LNs. (B) Comparison of percentages of CD27CD45RA+ (effector-type) cells within total and CMV-, EBV-, and FLU-specific CD8+ T cells between PB and LNs. (C) Comparison of the percentages of CD27+CD45RA+ (naive) cells within total CD8+ T cells between PB and LNs. Paired samples were analyzed using the Wilcoxon signed-rank test.

Close Modal

or Create an Account

Close Modal
Close Modal